DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Isoprenaline

Isoprenaline

  • Genl:VE 1970 © World Health Organization 1970

    Genl:VE 1970 © World Health Organization 1970

  • S1 Figa

    S1 Figa

  • Sympathoadrenergic Modulation of Hematopoiesis: a Review of Available Evidence and of Therapeutic Perspectives

    Sympathoadrenergic Modulation of Hematopoiesis: a Review of Available Evidence and of Therapeutic Perspectives

  • (12) United States Patent (10) Patent No.: US 9,376.418 B2 Haidle Et Al

    (12) United States Patent (10) Patent No.: US 9,376.418 B2 Haidle Et Al

  • Marrakesh Agreement Establishing the World Trade Organization

    Marrakesh Agreement Establishing the World Trade Organization

  • Effect of Rutin on the Isolated Rat Duodenum and Comparison with the Effects of Adrenaline, Isoprenaline and Papaverine

    Effect of Rutin on the Isolated Rat Duodenum and Comparison with the Effects of Adrenaline, Isoprenaline and Papaverine

  • Data Sheet Template

    Data Sheet Template

  • OUH Formulary Approved for Use in Breast Surgery

    OUH Formulary Approved for Use in Breast Surgery

  • Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

    Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

  • Cannabinoid CB1 and CB2 Receptors Antagonists AM251 and AM630

    Cannabinoid CB1 and CB2 Receptors Antagonists AM251 and AM630

  • Pharmacology

    Pharmacology

  • Beta Adrenergic Receptor of Rabbit Thoracic Aorta in Relation to Age

    Beta Adrenergic Receptor of Rabbit Thoracic Aorta in Relation to Age

  • 1. NAME of the DRUG Isoprenaline Hydrochloride S.A.L.F. 0.2 Mg/Ml Solution for Injection

    1. NAME of the DRUG Isoprenaline Hydrochloride S.A.L.F. 0.2 Mg/Ml Solution for Injection

  • Electrocardiographic Effects of Isoprenaline in Normal Subjects and Patients with Coronary Atherosclerosis1

    Electrocardiographic Effects of Isoprenaline in Normal Subjects and Patients with Coronary Atherosclerosis1

  • PAPER SPRAY MASS SPECTROMETRY for RAPID DRUG SCREENING by Rachel Jett

    PAPER SPRAY MASS SPECTROMETRY for RAPID DRUG SCREENING by Rachel Jett

  • Stembook 2018.Pdf

    Stembook 2018.Pdf

  • The Inhibition of Noradrenaline Uptake by Sympathomimetic Amines in the Rat Isolated Heart

    The Inhibition of Noradrenaline Uptake by Sympathomimetic Amines in the Rat Isolated Heart

  • Ultraviolet-Visible Reference Spectra E to L

    Ultraviolet-Visible Reference Spectra E to L

Top View
  • Pharmaceuticals (Monocomponent Products) ………………………..………… 31 Pharmaceuticals (Combination and Group Products) ………………….……
  • 2021 Equine Prohibited Substances List
  • Mechanisms of Tolerance and Dependence, 54
  • Drug/Substance Trade Name(S)
  • Pegylated Isoprenaline Reveals Distinct Functions of Cardiac Β-Adrenergic Receptors Located in the T-Tubule Vs. Outer Surface Membrane
  • 3399-3406-Aparna Natarajan-Suppl 8.Pdf
  • Assessment of Dronabinol and Its Stereo-Isomers1,2
  • Enantiomeric Recognition and Separation by Chiral Nanoparticles
  • Pharmacological Identification of Β-Adrenoceptor Subtypes Mediating Isoprenaline-Induced Relaxation of Guinea Pig Colonic Longitudinal Smooth Muscle
  • Diphenylmethylene)- 4-Azatricyclo[5.2.1.02,6]Dec-8-Ene-3,5-Dione Derivatives
  • United States Patent Office 3,732,300
  • Long-Term Safety of Droxidopa in Patients with Symptomatic
  • Isoprenaline (Isoproterenol)
  • )&F1y3x PHARMACEUTICAL APPENDIX to THE
  • United States Patent (10) Patent No.: US 7,723,348 B2 Hopper Et Al
  • Pharmacology
  • Protocol for the Iv Administration of Isoprenaline
  • United States Patent Office 3,644,353


© 2024 Docslib.org    Feedback